| [1] |
张之南, 单澜东. 协和血液学. 北京: 中国协和医科大学出版社, 2004: 376-377. |
| [2] |
Pui CH, Evans WE.
Treatment of acute lymphoblastic leukemia[J]. N Engl J MedN Engl J Med, 2006, 354(2): 166-178.
doi: 10.1056/NEJMra052603 |
| [3] |
张之南, 沈悌. 血液病诊断及疗效标准. 2版. 北京: 科学出版社, 1998: 171-186. |
| [4] |
Thomas DA, Faderl S, Cortes J, et al.
Treatment of philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate[J]. BloodBlood, 2004, 103(12): 4396-4407.
doi: 10.1182/blood-2003-08-2958 |
| [5] |
Jurisicy V, Kraguljac N, Konjevic G, et al.
TNF-alpha induced change in cell membrane antigen expression on K-562 cells associated with increased lactate dehydrogenase(LDH)release[J]. NeoplasmaNeoplasma, 2005, 52(1): 25-31.
|
| [6] |
Tramèr MR, Carroll D, Campbell FA, et al.
Cannadinoids for control of chemotherapy induced nausea and vomiting quantitative systematic review[J]. BMJBMJ, 2001, 323(7303): 16-21.
doi: 10.1136/bmj.323.7303.16 |
| [7] |
Ottmann OG, Wasssman B, Pfeifer H, et al.
lmatinib compared with chemotherapy as frint-line treatment of elderly patients with philadelphia chromosome-positive acute lymphoblastic leukemia(ph+ALL)[J]. CancerCancer, 2007, 109(10): 2068-2076.
doi: 10.1002/cncr.22631 |
| [8] |
Tallman MS, Kim HT, Paietta E, et al.
Acute monocytic leukemia(French-American-British classification M5)does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group[J]. J Clin OncolJ Clin Oncol, 2004, 22(7): 1276-86.
doi: 10.1200/JCO.2004.08.060 |